Шломо Мелмед
- Endocrinology, Diabetes and Metabolism top 0.01%
- Surgery top 0.1%
- Molecular Biology top 0.5%
- Epidemiology top 0.2%
- Genetics top 0.1%
- Co-authors
- John WassAnthony P. HeaneyAnat Ben-ShlomoFelipe F. CasanuevaShunichi YamashitaDavid L. KleinbergAndrea GiustinaVera Chesnokova
- Topics
- Pituitary Gland Disorders and Treatments (286 papers)Growth Hormone and Insulin-like Growth Factors (282 papers)Cancer, Hypoxia, and Metabolism (73 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Шломо Мелмед
467 papers receiving 30.4k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Endocrinology, Diabetes and Metabolism 23.1k
- Surgery 7.5k
- Molecular Biology 6.7k
- Epidemiology 6.0k
- Genetics 3.4k
Countries citing papers authored by Шломо Мелмед
This map shows the geographic impact of Шломо Мелмед's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Шломо Мелмед with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Шломо Мелмед more than expected).
Fields of papers citing papers by Шломо Мелмед
This network shows the impact of papers produced by Шломо Мелмед. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Шломо Мелмед. The network helps show where Шломо Мелмед may publish in the future.
Co-authorship network of co-authors of Шломо Мелмед
This figure shows the co-authorship network connecting the top 25 collaborators of Шломо Мелмед. A scholar is included among the top collaborators of Шломо Мелмед based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Шломо Мелмед. Шломо Мелмед is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 21 | |
| 3 | 14 | |
| 4 | 97 | |
| 5 | 157 | |
| 6 | 54 | |
| 7 | 25 | |
| 8 | Guidelines for Acromegaly Management: An Updatebreakdown → | 549 |
| 9 | 51 | |
| 10 | 113 | |
| 11 | 59 | |
| 12 | 207 | |
| 13 | 81 | |
| 14 | 144 | |
| 15 | 122 | |
| 16 | 1 | |
| 17 | 86 | |
| 18 | 22 | |
| 19 | 323 | |
| 20 | 90 |
About Шломо Мелмед
Шломо Мелмед is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Behavioral Neuroscience, having authored 477 papers that have together received 31.2k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (286 papers), Growth Hormone and Insulin-like Growth Factors (282 papers) and Cancer, Hypoxia, and Metabolism (73 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (23.1k citations), Genetics (3.4k citations) and Cancer Research (2.9k citations). Шломо Мелмед has collaborated with scholars based in United States, Germany and France. Frequent co-authors include John Wass, Anthony P. Heaney, Anat Ben-Shlomo, Felipe F. Casanueva, Shunichi Yamashita, David L. Kleinberg, Andrea Giustina, Vera Chesnokova, Christoph J. Auernhammer and Philippe Chanson. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.